Synmosa is a specialty pharmaceutical corporation that engages in diversified development that includes acting as an agent, manufacturing, OEM, and R&D. We have adhered to our corporate motto “Honesty, Credibility, Reliability, and Innovation” in the development and manufacture of pharmaceuticals ever since its establishment in 1980.
The Synmosa Group, guided by our corporate strategy of sustainable development:“organic growth, continuous mergers and acquisitions, and strategic alliances”, has established factories in Hsinchu Hukou, Taichung, and New Taipei City through vertical expansion and horizontal integration. Synmosa optimizes its operations in response to international specifications, and is one of the few pharmaceutical groups in Taiwan that are moving towards “automation, maximization, and specialization.” We use our advantage in niche technology platforms: MDI, sex hormones, nasal sprays, effervescent tablets, and granules for our positioning. We excel in cardiovascular, respiratory, sex hormones, urology, and oncology oriented therapeutic products. Synmosa has special technical platforms that are internationally competitive and have allowed us to lock on to niche market products. Brand drugs and new drugs are now a focal point for the company. The key to our continuous and stable growth is a focus on high threshold special technology and characteristic pharmaceuticals and we provide our customers with the very best pharmaceuticals.
Synmosa business has expanded into the international market and our global network includes substantial investment in Taiwan, Hong Kong and China where we have created our own excellent marketing teams and strategic partners. We also have long-term partners in Finland, France, Japan, Australia, Thailand, Singapore, and several other Southeast Asian countries. Our most recent establishment is an office in Vietnam opened specifically to speed up market development in the region. We have set our eyes on Asia from our strong position in Taiwan and we are using systematic process management, firm ideas, and future insight for new pharmaceutical development, drug production processes, marketing, warehousing and logistics. We insist on using the highest standard of pharmaceutical manufacturing technology to improve the quality of people’s lives. Synmosa is doing our part by giving back to society and actively participating in social welfare. We remain committed to our core values “honesty, credibility, reliability, and innovation” to maximize the value we create for society and our shareholders as we move towards our vision of becoming the foremost specialty biopharmaceutical corporation in Asia.
Our Brand Identity
The Synmosa brand identity symbolizes the beginning of life and hope and continuation. The “S” – the initial letter of Synmosa – is integrated into the design to show the stable and practical nature of Synmosa. The extended curves, in turn, represent insightful strategy and sustainable development. Our full name is written in lower case to express a tempered and humble attitude. We hope one day to become a leading pharmaceutical brand, a pioneer in the development of future health care that will create new value for the pharmaceutical industry.
Our promiseTo use Synmosa professionalism and insight to provide the best possible quality products for human health care.
Our advantageWe have long standing strength in five key technology platforms and figured therapeutic areas and our strong management team guided by corporate strategies of “self-growth, continuous mergers & acquisitions, and strategy alliance, makes us the best collaborator for domestic and international partners.
Our Core valueWe provide the best quality service to our clients by strict adherence to the spirit of honesty, credibility, reliability, and innovation.
Unlimited Innovation and Sustainable Development for Health
Synmosa positions itself as a specialty pharmaceutical company with a focus on human health. We concentrate on the development of unique technology and medications and aim to be the leading pharmaceutical brand with sustainable development. Unlimited innovation will allow Synmosa to create new values in the pharmaceutical industry and we will take advantage of the potential for development in future healthcare.